Journal of Cardiac Failure最新文献

{"title":"Denial for Advanced Heart Failure Therapies Due to Psychosocial Stressors: Who Comes Back?","authors":"KAYLA BUTTAFUOCO MD ,&nbsp;DANIEL DAUNIS MD ,&nbsp;TANDRA CARTER LMSW ,&nbsp;JOLAUNDA HOYE LMSW ,&nbsp;MAURA WEBB LCSW ,&nbsp;SHI HUANG PhD ,&nbsp;MARSHALL BRINKLEY MD ,&nbsp;JOANN LINDENFELD MD ,&nbsp;JONATHAN MENACHEM MD ,&nbsp;DAWN PEDROTTY MD PhD ,&nbsp;ANIKET RALI MD ,&nbsp;SUZANNE SACKS MD ,&nbsp;KELLY SCHLENDORF MD MHS ,&nbsp;HASAN SIDDIQI MD MSCI ,&nbsp;LYNNE STEVENSON MD ,&nbsp;SANDIP ZALAWADIYA MBBS ,&nbsp;LYNN PUNNOOSE MD","doi":"10.1016/j.cardfail.2024.08.057","DOIUrl":"10.1016/j.cardfail.2024.08.057","url":null,"abstract":"<div><h3>Background</h3><div>Psychosocial evaluations to assess candidacy for advanced heart failure therapies are not standardized across institutions, potentially contributing to disparities in approval for advanced therapies. Remediation rates of psychosocial stressors among patients with advanced HF and reconsideration for advanced therapies have not been well-described.</div></div><div><h3>Methods and Results</h3><div>We performed a retrospective, single-center study of 647 adults evaluated for heart transplant and ventricular assist device implantation between 2014 and 2020, of whom 89 (14%) were denied for psychosocial stressors, including caregiver, substance use, housing, financial, or mental health concerns. Later reevaluation occurred in 32 patients (36%), of whom 23 were then approved. Patients initially declined were mostly male (76%), White (74%), and urban (79%). Reevaluation occurred in more women than men (43% vs 34%), Black patients than White (43% vs 37%), and urban patients than rural (39% vs 28%). Patients had fewer psychosocial stressors at reevaluation (median 0.5) than at initial denial (median 2.0). Caregiver and substance use concerns were the most prevalent stressors in patients never returning for or subsequently denied at reevaluation.</div></div><div><h3>Conclusions</h3><div>Caregiver and substance use concerns were common in patients denied for psychosocial reasons. Future efforts should focus on early screening for these stressors and the implementation of a systematic reevaluation process.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 582-587"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142347282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Can't Rain on Our Parade: Highlights from the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2024","authors":"ALEXANDER G. HAJDUCZOK ,&nbsp;ELENA M. DONALD ,&nbsp;JENNIFER MANING ,&nbsp;QUENTIN YOUMANS ,&nbsp;NOSHEEN REZA","doi":"10.1016/j.cardfail.2024.10.001","DOIUrl":"10.1016/j.cardfail.2024.10.001","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 574-578"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142466329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Critical Time for Tafamidis in the Real World – Will the Data Support its First Mover Advantage?","authors":"Paloma Remior-Perez MD ,&nbsp;Sumeet Singh Mitter MD, MSc","doi":"10.1016/j.cardfail.2025.01.003","DOIUrl":"10.1016/j.cardfail.2025.01.003","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 534-537"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Examining Heart Failure Outcomes Amid Housing Insecurity","authors":"MARTINE WEBB MD ,&nbsp;NICHOLAS K. BROWNELL MD ,&nbsp;SONYA GABRIELIAN MD ,&nbsp;GREGG C. FONAROW MD ,&nbsp;BOBACK ZIAEIAN MD, PhD","doi":"10.1016/j.cardfail.2024.06.005","DOIUrl":"10.1016/j.cardfail.2024.06.005","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;How housing insecurity might affect patients with heart failure (HF) is not well characterized. Housing insecurity increases risks related to both communicable and noncommunicable diseases. For patients with HF, housing insecurity is likely to increase the risk for worse outcomes and rehospitalizations.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods and Results&lt;/h3&gt;&lt;div&gt;We analyzed hospitalizations due to HF in the United States by using the 2020 National Inpatient Sample and Nationwide Readmissions Database to evaluate the impacts of housing insecurity on HF outcomes and hospital use. Individuals were identified as having housing insecurity by using diagnostic International Classification of Disease (ICD)-10 codes. Demographics and comorbidities were compared between patients with HF with and without housing insecurity. An adjusted logistic regression was performed to evaluate the relationships between housing insecurity and socioeconomic status on in-hospital mortality. Using a Cox proportional hazards model, patients with HF and without housing insecurity were evaluated for the risk of all-cause and HF-specific readmissions over time. Of the 1,003,270 hospitalizations for HF in the U.S. in 2020, 16,150 were identified as having housing insecurity (1.6%), and 987,120 were identified as having no housing insecurity (98.4%). The median age of patients with housing insecurity who were hospitalized for HF was 57, as compared to 73 in the population with no housing insecurity. A higher proportion of patients in the housing-insecurity group were Black (35% vs 20.1%) or Hispanic (11.1% vs 7.3%). Patients with housing insecurity were more likely to carry a diagnosis of alcohol-use disorder (15.2% vs 3.3%) or substance-use disorder (70.2% vs 17.8%) but were less likely to use tobacco (18.3% vs 28.7%). Patients with housing insecurity were over 4.5 times more likely to have Medicaid (52.4% vs 11.3%). Median length of stay did not differ between patients with housing insecurity vs those without it. Patients with housing insecurity were more likely to discharge against medical advice (11.4% vs 2.03%). After adjusting for patients’ characteristics, housing insecurity was associated with lower in-hospital mortality rates (OR 0.60, 95% CI 0.39–0.92). Housing insecurity was associated with a higher risk of all-cause readmissions at 180 days (HR 1.13, 95% CI 1.12–1.14). However, there was no significant difference in the risk of HF-specific readmissions at 180 days (HR 1.07, 95% CI 0.998–1.14)&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Patients with HF and housing insecurity have distinct demographic characteristics. They are also more likely to be readmitted after their initial hospitalization when compared to those without housing insecurity. Identifying and addressing specific comorbid conditions for patients with housing insecurity who are hospitalized for HF may allow clinicians to provide more focused care, with the goal of preventing morbidity, m","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 511-520"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141544896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Balancing Fat Loss and Muscle Loss in the Quest to Reduce Obesity in Patients with Heart Failure","authors":"SHELDON E. LITWIN MD","doi":"10.1016/j.cardfail.2025.01.004","DOIUrl":"10.1016/j.cardfail.2025.01.004","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 508-510"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143038872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Our Second Mountain: Refining the Vision of JCF","authors":"Anuradha Lala MD ,&nbsp;Robert J. Mentz MD","doi":"10.1016/j.cardfail.2025.02.007","DOIUrl":"10.1016/j.cardfail.2025.02.007","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 495-496"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143600702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validating the Association Between Composite Metrics of Guideline-Directed Medical Therapy and Clinical Outcomes for Patients With Heart Failure With Reduced Ejection Fraction","authors":"ALEXANDRA STEVERSON MD, MPH ,&nbsp;JAMIE CALMA BA ,&nbsp;STEPHANIE HSIAO MD ,&nbsp;KARIM SALLAM MD ,&nbsp;ANUBODH S. VARSHNEY MD ,&nbsp;JESSICA R. GOLBUS MD, MS ,&nbsp;PAUL A. HEIDENREICH MD, MS ,&nbsp;ALEXANDER T. SANDHU MD, MS","doi":"10.1016/j.cardfail.2024.08.054","DOIUrl":"10.1016/j.cardfail.2024.08.054","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 588-591"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)","authors":"PABLO GARCIA-PAVIA MD, PhD ,&nbsp;ARNT V. KRISTEN MD ,&nbsp;BRIAN DRACHMAN MD ,&nbsp;MARTIN CARLSSON MS ,&nbsp;LESLIE AMASS PhD ,&nbsp;FRANCA STEDILE ANGELI MD, PhD ,&nbsp;MATHEW S. MAURER MD ,&nbsp;THAOS investigators","doi":"10.1016/j.cardfail.2024.06.003","DOIUrl":"10.1016/j.cardfail.2024.06.003","url":null,"abstract":"<div><h3>Background</h3><div>In the pivotal Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis significantly reduced mortality rates, leading to its approval in many countries for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). Real-world evidence on survival in patients with ATTR-CM following tafamidis treatment has not been extensively reported.</div></div><div><h3>Methods and Results</h3><div>The Transthyretin Amyloidosis Outcomes Survey (THAOS) was a longitudinal, observational, phase 4 study of patients with transthyretin amyloidosis and asymptomatic participants carrying pathogenic transthyretin variants. Patients from THAOS with a predominantly cardiac phenotype at enrollment were included, and survival was analyzed according to tafamidis treatment status (treated or untreated). Results are based on the completed THAOS dataset. In tafamidis-treated (n = 587) and tafamidis-untreated (n = 854) patients, respectively, median age at enrollment was 77.7 and 76.4 years, 91.8% and 90.0% were male, and 91.8% and 83.8% had wild-type disease. Survival rates (95% CI) at 30 and 42 months, respectively, were 84.4% (80.5–87.7) and 76.8% (70.9–81.7) in tafamidis-treated patients, and 70.0% (66.4-73.2) and 59.3% (55.2-63.0) in tafamidis-untreated patients. Survival rates in genotype subgroups (wild-type and variant) were similar to those of the overall cohort. Survival rates were better in a contemporary cohort, as reflected by a sensitivity analysis performed in patients enrolled after vs before 2019. No new safety signals were identified.</div></div><div><h3>Conclusions</h3><div>In this real-world cohort of patients with ATTR-CM, survival rates were higher than in ATTR-ACT and consistent with more recent reports, suggesting early diagnosis and treatment with tafamidis has improved life expectancy in ATTR-CM. These results provide further evidence supporting tafamidis’ safety and effectiveness.</div><div>Trial registration: ClinicalTrials.gov identifier: NCT00628745</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 3","pages":"Pages 525-533"},"PeriodicalIF":6.7,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of Environmental Temperature on the Occurrence of Driveline Infection in Patients With LVADs.","authors":"Filippo Calì, Alberto Pinsino, Annamaria Ladanyi, Giulio M Mondellini, Changhee Lee, Gabriel T Sayer, Yuji Kaku, Nir Uriel, Koji Takeda, Justin G Aaron, Melana Yuzefpolskaya, Paolo C Colombo","doi":"10.1016/j.cardfail.2025.01.024","DOIUrl":"10.1016/j.cardfail.2025.01.024","url":null,"abstract":"","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Differences Between Ischemic and Nonischemic Cardiomyopathy in Heart Failure Related Cardiogenic Shock.","authors":"Jason Feinman, Matthew I Tomey, Michael G Palazzolo, Miguel Martillo, Maria Ronquillo, Noah Moss, Gregory Serrao, Erin A Bohula, David D Berg, Sean VAN Diepen, Jason N Katz, Meshe D Chonde, Sunit-Preet Chaudhry, Alvin J George, Daniel Gerber, Michael J Goldfarb, Norma M Keller, Michael C Kontos, Daniel B Loriaux, Connor G O'Brien, Barbara A Pisani, Alastair Proudfoot, Kiran Sidhu, Shashank S Sinha, Lakshmi Sridharan, Natalie Tapaskar, Alexander Thomas, Andrea D Thompson, David A Morrow, Umesh Gidwani, Evan Leibner","doi":"10.1016/j.cardfail.2025.01.020","DOIUrl":"10.1016/j.cardfail.2025.01.020","url":null,"abstract":"<p><strong>Background: </strong>Heart failure-related cardiogenic shock (HF-CS) accounts for a growing proportion of cardiogenic shock (CS)-related admissions to contemporary cardiac intensive care units. Limited data exist comparing nonischemic (NICM) and ischemic cardiomyopathy (ICM) in this setting.</p><p><strong>Methods and results: </strong>We sought to examine the differences in patients' characteristics, in-hospital treatments and outcomes in individuals admitted with ICM and NICM HF-CS. The study population included CS admissions within the Critical Care Cardiology Trials Network registry from 2017-2022. CS due to acute myocardial infarction or secondary causes was excluded. Admission characteristics, in-hospital treatments and outcomes were captured. The primary outcome of all-cause in-hospital mortality for ICM vs NICM was compared by using multivariable logistic regression; 2463 hospital admissions for HF-CS, including 902 (36.6%) admissions with ICM and 1561 (63.4%) admissions with NICM, were included. Patients with ICM more commonly had pre-existing comorbidities, pre-admission cardiac arrest and higher Sequential Organ Failure Assessment scores. The use of inotropes and temporary mechanical circulatory support was similar; however, the rates of mechanical ventilation and renal-replacement therapies were higher for ICM. Patients with ICM were less likely to undergo cardiac transplantation but had similar rates of durable left ventricular assist device implantation. After multivariable adjustment, patients with ICM were significantly more likely to die during the index hospitalization (OR 1.56, 95% CI 1.26-1.93; P < 0.001).</p><p><strong>Conclusions: </strong>Among patients admitted to cardiac intensive care units with HF-CS, patients with ICM were sicker, less likely to undergo cardiac transplantation, and more likely to die when compared with patients with NICM.</p>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}